BSV receives exclusive marketing and distribution right for NexoBrid in India
To focus on providing safer burn treatments for women and armed forces
To focus on providing safer burn treatments for women and armed forces
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
The total investment is in the region of Rs 200 crore
It is currently available in tablet and injectable dosage forms
Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Time to combine innovation, access and technology to deliver positive patient outcomes
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated